Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?

Cardiology (Switzerland)

Volumn 131, Issue 4, 2015, Pages 225-227

  Reiner, Željko ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CYTOKINE; FATTY ACID; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FOLLOW UP; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINOPATHY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; HYPERTRIGLYCERIDEMIA; MALE;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; TRIGLYCERIDES;

EID: 84929687556     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000381304     Document Type: Note

References (22)

1. Reiner Ž, Catapano AL, De Backer G, et al: ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769-1818.
2. Perk J, De Backer G, Gohlke H, et al: European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012: 33; 1635-1617.
3. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25 suppl 2):S49-73.
4. Emerging Risk Factors Collaboration; Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J: Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000.
5. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration; Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J: Triglyceridemediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010; 375: 1634-1639.
6. Reiner Ž, De Bacquer D, Kotseva K, Prugger C, De Backer G, Wood D; EUROASPIRE III Study Group: Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Atherosclerosis 2013; 231: 300-307.
7. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of populationbased prospective studies. J Cardiovasc Risk 1996; 3: 213-219.
8. Sarwar N, Danesh J, Eiriksdottir G, et al: Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007; 115: 450-458.
9. Thomsen M, Varbo A, Tybjærg-Hansen A, Nordestgaard BG: Low nonfasting triglycerides and reduced all-cause mortality: a Mendelian randomization study. Clin Chem 2014; 60: 737-746.
10. Jørgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A: Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J 2013; 34: 1826-1833.
11. Miller M, Stone NJ, Ballantyne C, et al: Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292-2333.
12. Chapman MJ, Ginsberg HN, Amarenco P, et al; European Atherosclerosis Society Consensus Panel: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011; 332: 1345-1361.
13. Reiner Ž: Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Nutr Metab Cardiovasc Dis 2013; 23: 799-807.
14. Kim EH, Lee JB, Kim SH, Jo M-W, Hwang JY, Bae SJ, Jung CH, Lee WJ, Park J-Y, Park G-M, Kim Y-H, Kim H-K, Choe J: Serum triglyceride levels and cardiovascular disease events in Koreans. Cardiology 2015;131:228-235.
15. Iso H, Imano H, Yamagishi K, Ohira T, Cui R, Noda H, Sato S, Kiyama M, Okada T, Hitsumoto S, Tanigawa T, Kitamura A; CIRCS Investigators: Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2014; 237: 361-368.
16. Egeland GM, Igland J, Sulo G, Nygard O, Ebbing M, Tel GS. : Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: cohort Norway. Eur J Prev Cardiol 2014, E-pub ahead of print.
17. Fruchart J-C, Sacks F, Hermans MP, et al: A call to action to reduce residual vascular risk in dyslipidemic patients. A position paper by the Residual Risk Reduction Initiative (R 3 I). Diabetes Vasc Dis Res 2008; 4: 319-335.
18. Reiner Ž, Sonicki Z, Tedeschi-Reiner E: Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRODOC survey. Atherosclerosis 2010; 213: 598-603.
19. Reiner Ž, Sonicki Z, Tedeschi-Reiner E: Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey. Prev Med 2010; 51: 494-496.
20. Sacks FM, Hermans MP, Fioretto P, et al: Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation 2014; 129: 999-1008.
21. Holmes MV, Asselbergs FW, Palmer TM, et al: Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 2015; 36: 539-550.
22. Khetarpal SA, Rader DJ: Triglyceride-rich lipoproteins and coronary artery disease risk. New insights from human genetics. Arterioscler Thromb Vasc Biol 2015; 35:e3-e9.